Back    Zoom +    Zoom -
PHARMARON Places Shrs at 8.5% Discount to Raise ~HKD1.32B Net
Recommend
3
Positive
2
Negative
1
PHARMARON (03759.HK) announced plans to place around 58.4408 million new H-shares (about 3.19% of the enlarged issued share capital and around 16.57% of the total issued H-shares) at a price of HKD22.82 per share, about an 8.5% discount to yesterday's (14th) closing price.

The company expects the total and net proceeds from the placement to reach around HKD1.334 billion and HKD1.319 billion, respectively, with about 70% of them used for project construction to enhance laboratory service facilities, drug process development, and production facilities.

Related NewsCLSA: WUXI APPTEC (02359.HK) Top Picks in CN Pharma CRO/ CDMO Sectors, Expected to Outperform Peers This Yr

AAStocks Financial News